Adaptive Biotechnologies Corporation ADPT

Updated: 11 Aug 2026

NASDAQ | Biotech | Biotechnology and immune diagnostics

No signal published yet

We already track Adaptive Biotechnologies and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Adaptive Biotechnologies free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology and immune diagnostics
We're already tracking Adaptive Biotechnologies Corporation — here are the latest events we've registered

Recent News

  • On July 29, 2026, Adaptive Biotechnologies reported second-quarter 2026 financial results, with total revenue rising 22% year-over-year to $71.6 million driven by strong growth in its MRD segment. The company raised its full-year 2026 MRD revenue guidance to between $268 million and $278 million. Additionally, management outlined plans to strategically separate its Immune Medicine business from its profitable MRD diagnostic unit.

What Firelda Watch includes for Adaptive Biotechnologies Corporation

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Adaptive Biotechnologies Corporation will be delivered in the same format.

Want to follow Adaptive Biotechnologies Corporation? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Adaptive Biotechnologies free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Adaptive Biotechnologies Corporation ADPT
Adaptive Biotechnologies — follow and we'll monitor it
Follow Adaptive Biotechnologies free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.